Coherus Oncology Cash Flow Statement (2012-2025) | CHRS

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2012 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-172.95M-29.90M-38.53M-45.68M-96.08M-50.15M-86.65M-58.86M-75.73M-42.87M-39.64M-79.65M170.91M41.93M36.85M-4.60M-9.17M342.63M8.99M8.70M
Share-based Compensation (Quarter)
0.80M11.60M7.42M10.95M12.88M4.58M6.92M11.73M12.28M10.08M9.95M10.80M7.32M7.23M6.87M6.38M5.37M5.42M3.39M2.78M
Gains from Sales and Divestitures (Quarter)
0.47M0.81M1.28M2.79M0.53M
Gains from Investment Securities (Quarter)
1.73M0.23M0.24M0.02M2.66M0.30M0.03M0.85M2.78M0.05M0.03M0.94M0.28M0.77M0.31M-1.06M0.18M0.04M0.00M0.01M
Asset Writedowns and Impairment (Quarter)
-0.09M26.00M3.24M-0.35M1.48M48.23M6.80M-0.03M7.37M0.50M12.45M
Non-cash Items (Quarter)
61.40M51.50M37.40M17.01M2.33M
Cash from Operations (Quarter)
1.37M-0.19M13.71M-52.32M-54.05M-50.04M-37.09M-99.95M-68.73M-38.91M-54.30M-12.94M-46.77M59.73M-62.02M28.61M-25.83M-46.63M-46.34M-19.72M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.00M0.48M0.32M-4.25M3.70M0.32M0.62M0.80M1.34M0.24M0.26M-0.43M
Depreciation & Amortization (CF) (Quarter)
0.85M0.90M0.90M0.84M0.77M0.90M0.90M1.05M0.95M0.88M0.90M1.06M1.51M1.19M1.55M1.03M1.05M1.02M0.97M0.90M
Change in Working Capital
Change in Receivables (Quarter)
-16.66M1.42M-5.48M-13.34M-5.99M-1.34M-24.52M18.80M-8.53M39.88M75.28M44.06M-8.58M-76.64M-7.81M-56.33M-50.89M-55.27M4.27M8.34M
Change in Inventory (Quarter)
11.38M-7.52M-6.80M9.19M2.96M11.24M23.35M9.79M2.67M13.04M19.23M11.79M11.46M7.10M6.94M6.45M22.24M-3.77M-2.48M1.11M
Change in Account Payables (Quarter)
0.20M-0.98M31.27M-29.62M4.76M-3.33M-7.57M1.60M11.74M6.05M6.76M-0.79M0.62M39.46M-50.36M6.34M13.04M-12.21M-15.30M-5.09M
Change in Accured Expenses (Quarter)
16.90M9.56M-9.94M1.41M-3.24M-1.84M4.46M1.22M-10.19M0.89M16.52M3.69M0.74M-46.61M-5.03M-5.97M-8.32M1.00M-6.31M9.87M
Other Working Capital Changes (Quarter)
-2.11M-0.23M5.22M-2.30M-0.25M6.47M6.29M-13.21M-0.13M-4.66M4.86M-16.23M4.43M-11.60M11.48M-3.47M1.84M-2.23M-2.01M-62.04M
Investing Activities
Capital Expenditures (Quarter)
0.14M0.41M0.26M0.47M0.61M0.88M0.46M0.09M0.15M0.10M0.03M-187.82M-40.00M4.72M-483.40M8.38M
Sales of Property, Plant and Equipment (Quarter)
0.18M0.44M0.15M0.08M
Change in Intangibles (Quarter)
187.82M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
47.70M18.97M17.50M-4.22M131.08M6.20M2.49M19.81M
Cash from Investing Activities (Quarter)
-285.48M23.59M15.99M107.49M-35.62M-0.88M-0.46M-129.90M17.53M41.37M50.55M35.20M202.76M27.66M0.44M-0.54M-17.49M462.64M-67.23M-2.84M
Financing Activities
Other financing activities (Quarter)
1.73M-2.04M-0.18M-0.18M2.66M0.64M0.32M4.61M2.78M0.30M0.12M-0.20M0.74M1.71M0.01M2.43M0.26M0.02M0.00M1.14M
Cash from Financing Activities (Quarter)
2.44M46.85M1.10M1.49M-1.85M0.72M48.87M6.59M3.80M54.33M11.11M0.37M0.89M-187.93M-0.17M0.23M-0.26M-281.52M0.00M8.08M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-281.67M70.25M30.80M56.66M-91.52M-50.20M11.32M-223.26M-47.40M56.77M7.35M22.63M156.88M-100.53M-61.74M28.30M-43.58M134.48M-113.56M-14.47M
Free Cash Flow (Quarter)
1.22M-0.60M13.45M-52.79M-54.66M-50.92M-37.55M-100.04M-68.88M-39.02M-54.30M-12.97M141.06M99.73M-62.02M28.61M-30.55M436.77M-46.34M-28.09M
Net Cash Flow (Quarter)
-281.67M70.25M30.80M56.66M-91.52M-50.20M11.32M-223.26M-47.40M56.77M7.35M22.63M156.88M-100.53M-61.74M28.30M-43.58M134.48M-113.56M-14.47M